Jan Stahlberg, 10% Owner at DiaMedica Therapeutics Inc. (DMAC), bought 1,543,082 shares at $6.00 ($9.2M) on 2025-08-27, disclosed to the SEC on 2025-09-04.
Open-market purchase of $9.2M DMAC by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.91 | 293,601 | $1.7M | 18.9% |
| 2 | $5.91 | 293,601 | $1.7M | 18.9% |
| 3 | $5.99 | 70,414 | $422K | 4.6% |
| 4 | $5.99 | 70,414 | $422K | 4.6% |
| 5 | $6.00 | 8,233 | $49K | 0.5% |
| 6 | $5.86 | 71,107 |
| $417K |
| 4.5% |
| 7 | $5.86 | 71,107 | $417K | 4.5% |
| 8 | $5.96 | 48,172 | $287K | 3.1% |
| 9 | $5.96 | 48,172 | $287K | 3.1% |
| 10 | $5.96 | 59,788 | $356K | 3.9% |
| 11 | $5.96 | 59,788 | $356K | 3.9% |
| 12 | $6.00 | 338,265 | $2.0M | 22.1% |
| 13 | $6.00 | 59,648 | $358K | 3.9% |
| 14 | $6.00 | 50,772 | $305K | 3.3% |
| Total | $5.95 avg | 1,543,082 | $9.2M | 100% |
| Filing → |